Cuu Long Pharmaceutical Joint Stock Company provided earnings guidance for the fiscal year 2022. For the period, the company expects net revenue to be VND 845,510 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,500 VND | -0.70% | -2.40% | +14.00% |
1st Jan change | Capi. | |
---|---|---|
+14.00% | 82.37M | |
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |
- Stock Market
- Equities
- DCL Stock
- News Cuu Long Pharmaceutical
- Cuu Long Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2022